Drug Company to Equitably Share Revenue from Genetic Research with Indigenous Communities - PRESS AI WORLD
PRESSAI
Recent Posts
side-post-image
side-post-image
Politics

Drug Company to Equitably Share Revenue from Genetic Research with Indigenous Communities

share-iconTuesday, January 07 comment-icon2 weeks ago 5 views
News sources:
nytimesNYTIMES
Drug Company to Equitably Share Revenue from Genetic Research with Indigenous Communities

Credited from: NYTIMES

  • Variant Bio has reached a **$50 million collaboration** with Novo Nordisk, focusing on **metabolic disorders** such as diabetes.
  • The deal will allow Indigenous communities to receive a **share of the revenues** from the genetic research.
  • Dr. Stephane Castel emphasized a commitment not to **patent genes**, only the derived medicines.
  • This partnership aims to correct historical exploitation by ensuring **benefit-sharing** with participating communities.
  • Experts view this as a **positive step** toward rebuilding trust in Indigenous genetic research efforts.

For more details, visit the original article at The New York Times.

SHARE THIS ARTICLE:

nav-post-picture
nav-post-picture